• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Public Health

Exposure to air pollution is associated with increased risk of developing limitations in physical function

byJayden BerdugoandSimon Pan
February 17, 2026
in Public Health
Reading Time: 3 mins read
Risk of dementia with air pollution exposure amplified in patients with heart disease
Share on FacebookShare on Twitter

1. Greater long-term exposure to particulate matter (PM) and nitrogen dioxide (NO2) was associated with increased risk of progressing from no disability to physical limitations and activities of daily living (ADLs) disability. 

2. Higher ozone (O3) was associated with lower disability progression risk. 

Evidence Rating Level: 1 (Excellent) 

Study Rundown: Individuals have longer life expectancies, which has resulted in spending more years with physical disabilities, often adding emotional and financial burdens. Disability typically develops gradually, progressing from early physical limitations to difficulties with activities of daily living (ADLs). However, people can also move in and out of these states over time, as the process is not linear. Long-term exposure to air pollutants, such as particulate matter (PM), nitrogen dioxide (NO2), and ozone (O3), may contribute to the development of multiple chronic diseases. Past studies have examined these issues separately as opposed to a collective process. To address this research gap, this study aimed to contribute to previous research within the Health and Retirement Study (HRS) by examining the associations between long-term air pollution exposure and the transition between no physical limitations, physical function limitations, ADL disability, and death. Long-term exposure to higher levels of air pollution, particularly PM2.5, PM10-2.5, and NO2, is associated with increased progression and reduced recovery of physical disability in older adults. A key limitation is that the researchers only measured outdoor air pollution at participants’ homes, and did not account for indoor air quality or the amount of time participants spent away from home, resulting in inaccurate measurements. Despite this, the study suggests that reducing air pollution may help promote healthier aging.

Click here to read the study in JAMA Network Open 

Relevant Reading:  Long-term air pollution exposure and incident physical disability in older US adults: a cohort study

RELATED REPORTS

Chronic exposure to particulate matter is associated with increased cardiovascular risk

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

A landmark court ruling was associated with increased travel across state borders for abortion care

In-Depth [prospective cohort]: This prospective cohort study enrolled eligible participants older than 50 years from a diverse sample, with updates to the cohort every 6 years to maintain a representative sample. Physical function limitations and ADL disability were based on self-reported data. The study followed 29,790 adults (mean [SD] age, 63 [11] years, 16,878 [57%] women) for a mean (SD) duration of 8 (6) years. Higher long-term exposure to PM2.5, PM10-2.5, and NO2 was associated with an increased risk of transitioning from no physical limitations to physical disability. A 1-IQR increase in PM2.5 was associated with a 6% higher risk of developing physical function limitations (HR 1.06, 95% CI, 1.03-1.09), and a 4% risk of recovering back to no limitations (HR 0.96, 95% CI, 0.93-0.99). In contrast, greater exposure to ozone (O3) appeared to have a protective effect. A 1-IQR increase in O3 was associated with a lower risk of developing physical function limitations (HR 0.92, 95% CI, 0.86-0.98) and of progressing to ADL disability (HR 0.89, 95% CI, 0.81-0.97). Overall, this study highlights how air pollution may contribute to worsening disability in older adults, which is especially important given the extremely high cost of disability management on the government. Reducing air pollution could be an important strategy not only for improving health but also for potentially lowering long-term healthcare costs. 

Image: PD

©2026 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc. 

Tags: air pollutiondisabilityozoneparticulate matterphysical functionpublic health
Previous Post

One in Six Medicare Beneficiaries Use Telehealth for Essential Care

Next Post

2MM: AI Roundup- Medtronic’s AI-Robotic Spine Platform, 90% Phase I Success for AI-Designed Drugs, and UCSD’s AI Cancer Risk Predictor [Feb 17th, 2026]

RelatedReports

Cardiology

Chronic exposure to particulate matter is associated with increased cardiovascular risk

September 10, 2026
“Housing First” linked to housing stability for homeless youth with mental illness
Public Health

Mortality in the post-housing period is high among homeless people in Ottawa, Canada

August 31, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Obstetrics

A landmark court ruling was associated with increased travel across state borders for abortion care

August 28, 2026
Natural language processing may automate data extraction from radiologic reports
Chronic Disease

Many patients using patient portals may not fully understand results of laboratory testing

August 26, 2026
Next Post
2 Minute Medicine AI Roundup editorial illustration

2MM: AI Roundup- Medtronic’s AI-Robotic Spine Platform, 90% Phase I Success for AI-Designed Drugs, and UCSD’s AI Cancer Risk Predictor [Feb 17th, 2026]

Remote patient monitoring did not reduce heart failure readmissions: The BEAT-HF trial

Sodium-glucose cotransporter 2 inhibitors may improve left ventricular diastolic function in hypertrophic cardiomyopathy

2 Minute Medicine AI Roundup editorial illustration

FDA clears Medtronic stealth AXiS AI-Robotic spine system

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Nirsevimab (Beyfortus) may reduce severe respiratory syncytial virus infections among infants
  • An artificial intelligence (AI) tool achieved high diagnostic accuracy for the identification and prediction of sepsis
  • Use of long-acting broadly neutralizing antibodies may delay human immunodeficiency virus (HIV) rebound following discontinuation of antiretroviral therapy
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.